Trial Profile
A phase I trial of recombinant virus-like particle vaccine in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Feb 2017
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant monovalent GlaxoSmithKline MedImmune (Primary)
- Indications Human papillomavirus infections
- Focus Adverse reactions